PEEP Levels Selected by PEEP Titration and PEEP Levels Routinely Used in Post-operative Cardiac Patients With Hypoxemic Respiratory Failure

NCT02056977 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2017-11-22

No results posted yet for this study

Summary

The purpose of this study is to:

* Compare PEEP level selected by individualized PEEP titration by electrical impedance tomography and PEEP level routinely used in post-operative cardiac patients with Hypoxemic Respiratory Failure;
* Evaluate the agreement between the results of a rapid titration (total procedure duration = 5 min) versus an already validated slow titration (total procedure duration = 40 min) of the same patient, sequentially. Specifically, degree of collapse and degree of distention in each PEEP level, estimated by EIT;
* Compare hemodynamics during the two maneuvers of PEEP titration;
* Evaluate the efficacy of the selected PEEP (minimum PEEP preventing lung collapse less than 5%) to maintain stable levels of the following variables: arterial oxygenation, respiratory system compliance, and degree of collapse by EIT;
* Compare these results (evolution of the three variables, along 4 hours) with the control strategy (default strategy currently used in the institution) group.

Conditions

  • Post Operative Cardiac Surgery
  • ARDS
  • Hypoxemic Respiratory Failure

Interventions

OTHER

Titration

Individualized PEEP according to PEEP titration monitored by EIT

OTHER

control

PEEP selected according to a PaO2/FIO2 table as in the routines of the institution

Sponsors & Collaborators

  • Financiadora de Estudos e Projetos

    collaborator OTHER
  • University of Sao Paulo General Hospital

    lead OTHER

Principal Investigators

  • Marcelo BP Amato · Department of Cardio-Pulmonar, Pulmonary Division, Hospital das Clínicas, University of São Paulo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2017-12-31
Completion
2018-01-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02056977 on ClinicalTrials.gov